NZ530056A - Single administration of 1.5 mg levonorgestrel increases compliance and decreases possibility of incorrect use of this post-coital contraceptive - Google Patents
Single administration of 1.5 mg levonorgestrel increases compliance and decreases possibility of incorrect use of this post-coital contraceptiveInfo
- Publication number
- NZ530056A NZ530056A NZ530056A NZ53005602A NZ530056A NZ 530056 A NZ530056 A NZ 530056A NZ 530056 A NZ530056 A NZ 530056A NZ 53005602 A NZ53005602 A NZ 53005602A NZ 530056 A NZ530056 A NZ 530056A
- Authority
- NZ
- New Zealand
- Prior art keywords
- levonorgestrel
- active ingredient
- formulation
- application dose
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0105173A HU227198B1 (en) | 2001-11-27 | 2001-11-27 | Pharmaceutical composition for emergency contraception containing levonorgestrel |
| PCT/HU2002/000129 WO2003045397A1 (en) | 2001-11-27 | 2002-11-26 | Dosage regimen and pharmaceutical composition for emergency contraception |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ530056A true NZ530056A (en) | 2005-02-25 |
Family
ID=89998939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ530056A NZ530056A (en) | 2001-11-27 | 2002-11-26 | Single administration of 1.5 mg levonorgestrel increases compliance and decreases possibility of incorrect use of this post-coital contraceptive |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US20050288264A2 (https=) |
| EP (1) | EP1448207B1 (https=) |
| JP (1) | JP2005516904A (https=) |
| KR (1) | KR100908161B1 (https=) |
| CN (1) | CN1551774A (https=) |
| AP (1) | AP1849A (https=) |
| AT (1) | ATE293978T1 (https=) |
| AU (1) | AU2002347401A1 (https=) |
| BR (1) | BR0210595A (https=) |
| CA (1) | CA2450359C (https=) |
| DE (1) | DE60203929T2 (https=) |
| DK (1) | DK1448207T3 (https=) |
| EA (1) | EA006545B1 (https=) |
| EC (1) | ECSP045171A (https=) |
| ES (1) | ES2239727T3 (https=) |
| GE (1) | GEP20063882B (https=) |
| HR (1) | HRP20040584B1 (https=) |
| HU (1) | HU227198B1 (https=) |
| IL (1) | IL159394A0 (https=) |
| IS (1) | IS2691B (https=) |
| MA (1) | MA27076A1 (https=) |
| MX (1) | MXPA04005104A (https=) |
| NO (1) | NO333984B1 (https=) |
| NZ (1) | NZ530056A (https=) |
| OA (1) | OA12730A (https=) |
| PL (1) | PL206010B1 (https=) |
| PT (1) | PT1448207E (https=) |
| RS (1) | RS50768B (https=) |
| SI (1) | SI1448207T1 (https=) |
| TN (1) | TNSN04048A1 (https=) |
| UA (1) | UA79942C2 (https=) |
| WO (1) | WO2003045397A1 (https=) |
| ZA (1) | ZA200404114B (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008079245A2 (en) * | 2006-12-20 | 2008-07-03 | Duramed Pharmaceuticals, Inc. | Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof |
| BRPI0819571A2 (pt) * | 2007-12-20 | 2019-09-24 | Teva Womenss Health Inc | "método para contracepção de emergência, pacote farmacêutico para contracepção de emergência e composição farmacêutica" |
| US8512745B2 (en) | 2008-12-08 | 2013-08-20 | Laboratoire Hra Pharma | Ulipristal acetate tablets |
| EP2365811A1 (en) * | 2008-12-12 | 2011-09-21 | Laboratoire HRA Pharma | A method for contraception |
| BRPI1014035A2 (pt) | 2009-04-14 | 2016-04-12 | Hra Pharma Lab | método para contracepção. |
| CN102458386B (zh) * | 2009-06-23 | 2016-04-06 | 拜耳知识产权有限责任公司 | 用于紧急避孕的药物组合物 |
| CN101732324B (zh) * | 2009-12-31 | 2011-12-07 | 广州朗圣药业有限公司 | 一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法 |
| SG195118A1 (en) | 2011-06-01 | 2013-12-30 | Estetra S A | Process for the production of estetrol intermediates |
| PT2714712T (pt) | 2011-06-01 | 2016-11-08 | Estetra Sprl | Processo para a produção de intermediários de estetrol |
| EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
| PL2741824T3 (pl) * | 2011-08-11 | 2018-03-30 | Estetra S.P.R.L. | Zastosowanie estetrolu jako środka antykoncepcji awaryjnej |
| CN104797258A (zh) | 2012-11-22 | 2015-07-22 | 拜耳药业股份公司 | 包含左炔诺孕酮和cox抑制剂的药物组合物用于按需避孕的用途和施用方法 |
| EP2999469A1 (de) | 2013-05-23 | 2016-03-30 | Bayer Pharma Aktiengesellschaft | Pharmazeutische zusammensetzung und deren verwendung sowie anwendungsregime dieser pharmazeutischen zusammensetzung zur bedarfsweisen ( on-demand") kontrazeption |
| CN103877058A (zh) * | 2014-03-26 | 2014-06-25 | 邵娜 | 一种左炔诺孕酮片及其制备工艺 |
| LT3310345T (lt) | 2015-06-18 | 2021-06-25 | Estetra Sprl | Burnoje disperguojama tabletė, turinti estetrolio |
| LT3310346T (lt) | 2015-06-18 | 2021-06-10 | Estetra Sprl | Burnoje disperguojama tabletė, turinti estetrolio |
| DK3701944T3 (da) | 2015-06-18 | 2022-03-14 | Estetra Srl | Oro-dispergerbar doseringsenhed indeholdende en estetrolkomponent |
| CR20180042A (es) | 2015-06-18 | 2018-05-03 | Mithra Pharmaceuticals S A | Unidad de dosificación orodispersable que contiene un componente estetrol. |
| KR102712911B1 (ko) | 2016-08-05 | 2024-10-04 | 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 | 월경통 및 생리통의 관리방법 |
| CN111989105B (zh) | 2018-04-19 | 2024-07-19 | 埃斯特拉私人有限责任公司 | 化合物以及它们在缓解绝经相关症状中的用途 |
| TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
| CN110917154A (zh) * | 2019-12-12 | 2020-03-27 | 上海信谊天平药业有限公司 | 一种左炔诺孕酮片的制备方法 |
| TWI893101B (zh) | 2020-04-16 | 2025-08-11 | 比利時商埃斯特拉有限責任公司 | 具有降低之副作用之避孕組成物 |
| WO2022026901A2 (en) * | 2020-07-30 | 2022-02-03 | Acer Therapeutics Inc. | Nk antagonists for contraception |
| CN119523923A (zh) * | 2024-11-21 | 2025-02-28 | 华中药业股份有限公司 | 一种左炔诺孕酮片及其制备方法 |
-
2001
- 2001-11-27 HU HU0105173A patent/HU227198B1/hu unknown
-
2002
- 2002-11-26 NZ NZ530056A patent/NZ530056A/en not_active IP Right Cessation
- 2002-11-26 SI SI200230132T patent/SI1448207T1/xx unknown
- 2002-11-26 EP EP02783334A patent/EP1448207B1/en not_active Expired - Lifetime
- 2002-11-26 PL PL369520A patent/PL206010B1/pl unknown
- 2002-11-26 KR KR1020047002069A patent/KR100908161B1/ko not_active Expired - Lifetime
- 2002-11-26 EA EA200400731A patent/EA006545B1/ru unknown
- 2002-11-26 IL IL15939402A patent/IL159394A0/xx unknown
- 2002-11-26 CN CNA028137523A patent/CN1551774A/zh active Pending
- 2002-11-26 CA CA2450359A patent/CA2450359C/en not_active Expired - Lifetime
- 2002-11-26 ES ES02783334T patent/ES2239727T3/es not_active Expired - Lifetime
- 2002-11-26 PT PT02783334T patent/PT1448207E/pt unknown
- 2002-11-26 AU AU2002347401A patent/AU2002347401A1/en not_active Abandoned
- 2002-11-26 GE GE5567A patent/GEP20063882B/en unknown
- 2002-11-26 MX MXPA04005104A patent/MXPA04005104A/es active IP Right Grant
- 2002-11-26 BR BR0210595-0A patent/BR0210595A/pt not_active Application Discontinuation
- 2002-11-26 AT AT02783334T patent/ATE293978T1/de active
- 2002-11-26 RS YUP-42/04A patent/RS50768B/sr unknown
- 2002-11-26 OA OA1200400148A patent/OA12730A/fr unknown
- 2002-11-26 WO PCT/HU2002/000129 patent/WO2003045397A1/en not_active Ceased
- 2002-11-26 HR HR20040584 patent/HRP20040584B1/xx not_active IP Right Cessation
- 2002-11-26 AP APAP/P/2004/003046A patent/AP1849A/en active
- 2002-11-26 DK DK02783334T patent/DK1448207T3/da active
- 2002-11-26 JP JP2003546899A patent/JP2005516904A/ja not_active Withdrawn
- 2002-11-26 UA UA20040504015A patent/UA79942C2/uk unknown
- 2002-11-26 DE DE60203929T patent/DE60203929T2/de not_active Expired - Lifetime
-
2003
- 2003-12-05 IS IS7065A patent/IS2691B/is unknown
-
2004
- 2004-03-26 TN TNP2004000048A patent/TNSN04048A1/en unknown
- 2004-04-20 NO NO20041607A patent/NO333984B1/no not_active IP Right Cessation
- 2004-04-21 MA MA27643A patent/MA27076A1/fr unknown
- 2004-05-26 ZA ZA2004/04114A patent/ZA200404114B/en unknown
- 2004-06-25 EC EC2004005171A patent/ECSP045171A/es unknown
- 2004-10-05 US US10/495,923 patent/US20050288264A2/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2450359C (en) | Dosage regimen and pharmaceutical composition for emergency contraception | |
| CN102458386B (zh) | 用于紧急避孕的药物组合物 | |
| KR100849919B1 (ko) | 에스트로겐 대체 요법으로 치료중인 여성의 호르몬결핍증을 치료하기 위한 에스트로겐 및 안드로겐의 조합 | |
| JP2002509524A (ja) | エストロゲン化合物とプロゲステロン様化合物よりなるホルモン組成物 | |
| JP2003048836A (ja) | 効能を保持し無月経を引き起こす超低用量の経口避妊薬 | |
| AU747710B2 (en) | Progestogen-antiprogestogen regimens | |
| CN117715644A (zh) | 纯孕激素口服避孕 | |
| HK40108056A (zh) | 纯孕激素口服避孕 | |
| HK1070275A (en) | Dosage regimen and pharmaceutical composition for emergency contraception | |
| KR20010110807A (ko) | 조합 치료에서의 항프로게스타겐의 용도 | |
| HK1170686B (en) | Pharmaceutical composition for emergency contraception | |
| JP2007197459A (ja) | 月経の出血を少なくし維持された効力を持つ超低投与量避妊薬 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 7 YEARS UNTIL 26 NOV 2022 BY DENNEMEYER + CO Effective date: 20140822 |
|
| EXPY | Patent expired |